N/A
Completed N=500
Registry of AngioJet Use in the Peripheral Vascular System
Source: ClinicalTrials.gov NCT01086215 ↗Enrolled (actual)
500
Serious AEs
0.8%
Results posted
Nov 2014
Primary outcomePrimary: Change in Degree of Occlusion From Baseline to Final Angiogram/Venogram. — 1.31; 1.33; 1.36; 1.80 Units on a Scale — p=<0.0001
Summary
The Registry involves the collection of information for research and educational purposes only on the use of AngioJet in the peripheral vascular system.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Degree of Occlusion From Baseline to Final Angiogram/Venogram. |
1.31; 1.33; 1.36; 1.80; 3.76; 3.73 | <0.0001 sig |
| PRIMARY Rethrombosis |
21; 22; 15; 0; 9; 4 | — |
| SECONDARY Concomitant Treatments Used With the AngioJet® System |
102; 94; 67; 6; 146; 175 | — |
Eligibility Criteria
Inclusion Criteria
- Patient has been treated in the peripheral vascular system with any of the AngioJet System catheters.
- Patient has provided appropriate consent/authorization per the site's institutional policy and procedure.
Exclusion Criteria
- Patient has previously been enrolled in either the PEARL Registry or the PEARL II Registry in the last 12months.
Data sourced from ClinicalTrials.gov (NCT01086215). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.